Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant (2012)
- Authors:
- Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- DOI: 10.1016/j.vaccine.2011.12.034
- Assunto: MICROBIOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AMORIM, Jaime Henrique et al. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine, v. 30, n. 5, p. 837-845, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2011.12.034. Acesso em: 20 jan. 2026. -
APA
Amorim, J. H., Diniz, M. O., Cariri, F. A. M. O., Rodrigues, J. F., Bizerra, R. S. P., Gonçalves, A. J. S., et al. (2012). Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine, 30( 5), 837-845. doi:10.1016/j.vaccine.2011.12.034 -
NLM
Amorim JH, Diniz MO, Cariri FAMO, Rodrigues JF, Bizerra RSP, Gonçalves AJS, Alves AM de B, Ferreira LC de S. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant [Internet]. Vaccine. 2012 ; 30( 5): 837-845.[citado 2026 jan. 20 ] Available from: https://doi.org/10.1016/j.vaccine.2011.12.034 -
Vancouver
Amorim JH, Diniz MO, Cariri FAMO, Rodrigues JF, Bizerra RSP, Gonçalves AJS, Alves AM de B, Ferreira LC de S. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant [Internet]. Vaccine. 2012 ; 30( 5): 837-845.[citado 2026 jan. 20 ] Available from: https://doi.org/10.1016/j.vaccine.2011.12.034 - Bacillus subtilis e vacinas: avanços na pesquisa de veículos vacinais baseados em linhagens geneticamente modificadas de B. subtilis
- Functional and immunological characterization ofa natural polymorphic variantofa heat-labile toxin(LT-I)produced by enterotoxigenicEscherichia coli (ETEC)
- Effect of gender on training-induced vascular remodeling in SHR
- Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli
- A therapeutic Her2/neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her2/neu–expressing tumor in HLA-A2 transgenic mice
- Biosensor-based selective detection of Zika virus specific antibodies in infected individuals
- Immunomodulatory properties of the enterotoxigenic Escherichia coli type IIa heat-labile enterotoxin (LT-IIa) in mice immunized via the intradermal route
- Study of the natural diversity of heat-labile toxins (LT) produced by enterotoxigenic escherichia coli (ETEC) strains human-derived as an approach for the discovery of new vaccine adjuvants
- Vaccine development using live Salmonella enterica SV typhimurium strains deleted in flagellin -encoding genes using lambda red recombination approach
- Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1
Informações sobre o DOI: 10.1016/j.vaccine.2011.12.034 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
